Relationship between Use of Hydroxyurea and Cholelithiasis in Patients with Major and Intermediate β-thalassemia

AbstractBackground and Purpose: Cholelithiasis is a common problem among patients with homozygous major and intermediate β-thalassemia due to chronic hemolysis, ineffective erythropoesis and other factors that causes variety of side effects. Hydroxyurea (HU) decreases hemolysis by increasing HbF pro...

Full description

Bibliographic Details

Published in:	Journal of Mazandaran University of Medical Sciences
Main Authors:	H. Karami, M.D., K. Vahidshahi, M.D., M. Kosarian, M.D, H. Karami, M.D, M. Jamali, M.D
Format:	Article
Language:	English
Published:	Mazandaran University of Medical Sciences 2007-01-01
Subjects:	Major β-thalassemia Intermediate β-thalassemia Cholelithiasis Hydroxyurea
Online Access:	http://www.mazums.ac.ir/index.php?digital_library&do=downloadPdf&sid=548